Dr. Miguel Escobar discusses the data and considerations for using rFVIIa to manage bleeds in congenital hemophilia patients undergoing surgery, including a case study for a total knee replacement in a patient with inhibitors.
Dr. Miguel Escobar discusses the data and considerations for using rFVIIa to manage bleeds in congenital hemophilia patients undergoing surgery, including a case study for a total knee replacement in a patient with inhibitors.
Please click here for prescribing information.
Dr. Miguel Escobar discusses the data and considerations for using rFVIIa to manage bleeds in congenital hemophilia patients undergoing surgery, including a case study for a total knee replacement in a patient with inhibitors.
Please click here for prescribing information.
WARNING: THROMBOSIS
NovoSeven® RT (coagulation Factor VIIa, recombinant) is a coagulation factor indicated for:
WARNING: THROMBOSIS